| 2RF5 |
2.3 |
Crystal structure of human tankyrase 1- catalytic PARP domain |
| 3UDD |
1.95 |
Tankyrase-1 in complex with small molecule inhibitor |
| 3UH2 |
2.0 |
Tankyrase-1 in complexed with PJ34 |
| 3UH4 |
2.0 |
TANKYRASE-1 complexed with NVP-XAV939 |
| 4DVI |
1.9 |
Crystal structure of Tankyrase 1 with IWR2 |
| 4I9I |
2.4 |
Crystal structure of tankyrase 1 with compound 4 |
| 4K4E |
2.3 |
Co-crystal structure of tnks1 with compound 52 [N~2-(5-chloro-2-methoxyphenyl)-N-[trans-4-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)cyclohexyl]glycinamide] |
| 4K4F |
2.9 |
Co-crystal structure of TNKS1 with compound 18 [4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-N-(quinolin-8-yl)benzamide] |
| 4KRS |
2.29 |
Tankyrase-1 complexed with small molecule inhibitor |
| 4LI6 |
2.05 |
TANKYRASE-1 Complexed with small molecule inhibitor N-[(4-oxo-3,4-dihydroquinazolin-2-yl)methyl]-3-phenyl-N-(thiophen-2-ylmethyl)propanamide |
| 4LI7 |
2.2 |
TANKYRASE-1 complexed with small molecule inhibitor 4-chloro-5-cyano-N-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-2-methoxybenzamide |
| 4LI8 |
2.521 |
TANKYRASE-1 complexed with small molecule inhibitor 2-[4-(4-fluorobenzoyl)piperidin-1-yl]-N-[(4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrimidin-2-yl)methyl]-N-(thiophen-2-ylmethyl)acetamide |
| 4MSG |
1.8 |
Crystal structure of tankyrase 1 with compound 22 |
| 4MSK |
2.3 |
Co-crystal structure of tankyrase 1 with compound 34 |
| 4MT9 |
2.0 |
Co-crystal structure of tankyrase 1 with compound 49 |
| 4N3R |
1.9 |
Co-crystal structure of tankyrase 1 with compound 2 (5-(2-aminoquinazolin-6-yl)-N-(4,4-dimethyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)-2-fluorobenzamide) |
| 4N4V |
2.0 |
Co-crystal structure of tankyrase 1 with compound 4 [(4S)-3-{trans-4-[6-amino-5-(pyrimidin-2-yl)pyridin-3-yl]cyclohexyl}-5,5-dimethyl-4-phenyl-1,3-oxazolidin-2-one] |
| 4OA7 |
2.301 |
Crystal structure of Tankyrase1 in complex with IWR1 |
| 4TOR |
1.501 |
Crystal structure of Tankyrase 1 with IWR-8 |
| 4TOS |
1.802 |
Crystal structure of Tankyrase 1 with 355 |
| 4U6A |
2.37 |
X-ray crystal structure of human TNKS in complex with a small molecule inhibitor |
| 4UUH |
2.52 |
X-ray crystal structure of human TNKS in complex with a small molecule inhibitor |
| 4UW1 |
3.37 |
X-ray crystal structure of human TNKS in complex with a small molecule inhibitor |
| 4W5S |
2.8 |
Tankyrase in complex with compound |
| 4W6E |
1.95 |
Human Tankyrase 1 with small molecule inhibitor |
| 5EBT |
2.24 |
Tankyrase 1 with Phthalazinone 2 |
| 5ECE |
2.2 |
Tankyrase 1 with Phthalazinone 1 |
| 5ETY |
2.9 |
Crystal Structure of human Tankyrase-1 bound to K-756 |
| 5GP7 |
1.502 |
Structural basis for the binding between Tankyrase-1 and USP25 |
| 5JHQ |
3.2 |
ARCs 1-3 of human Tankyrase-1 bound to a peptide derived from IRAP |
| 5JTI |
2.9 |
Crystal structure of the human Tankyrase 1 (TNKS) SAM domain (D1055R), crystal form 2 |
| 5JU5 |
2.5 |
Crystal structure of the human Tankyrase 1 (TNKS) SAM domain (D1055R), crystal form 1 |
| 5KNI |
2.5 |
Crystal Structure of the wild-type SAM domain of human Tankyrase-1 |
| 6QXU |
1.2 |
Human TNKS1 in complex with 6,8-Difluoro-2-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-3H-quinazolin-4-one |
| 6URQ |
2.05 |
Complex structure of human poly-ADP-ribosyltransferase TNKS1 ARC2-ARC3 and P antigen family member 4 (PAGE4) |
| 7KKM |
1.58 |
Structure of the catalytic domain of tankyrase 1 |
| 7KKN |
1.48 |
Structure of the catalytic domain of tankyrase 1 in complex with talazoparib |
| 7KKO |
1.56 |
Structure of the catalytic domain of tankyrase 1 in complex with olaparib |
| 7KKP |
1.4 |
Structure of the catalytic domain of tankyrase 1 in complex with niraparib |
| 7KKQ |
1.59 |
Structure of the catalytic domain of tankyrase 1 in complex with veliparib |
| 7OCV |
1.432 |
Human TNKS1 in complex with 3-[4-(1-Hydroxy-1-methyl-ethyl)-phenyl]-6-methyl-2H-pyrrolo[1,2-a]pyrazin-1-one |
